(Q33993384)

30 July 2017

title

5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum (English)

1 reference

(3S,10S,13R,14R,17S)-17-[(E,2R)-7-hydroxy-6-methylhept-5-en-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-ol

30 July 2017

1 reference

1 reference

1 reference

15alpha,26-Dihydroxy-5alpha-lanosta-7,9(11),24-triene-3-one

1 reference

1 reference

1 reference

1 reference

(2R)-2-[(3S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylheptane-1,5,6-triol

1 reference

Lanosta-7,9(11)-diene-3,24,25-triol

1 reference

1 reference

1 reference

6-[(5R,10S,13R,14R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

1 reference

1 reference

5alpha-Lanosta-7,9(11)-diene-3beta,24,25,26-tetraol

1 reference

(3beta,24S)-Lanost-7,9(11)-diene-3,24,25-triol-

1 reference

17-(7-hydroxy-6-methylhept-5-en-2-yl)-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-ol

1 reference

(2S,3S,6R)-6-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptane-1,2,3-triol

1 reference

(6R)-6-[(3S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptane-1,2,3-triol

1 reference

(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R,5S)-5,6,7-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one

1 reference

15-Hydroxy-17-(7-hydroxy-6-methylhept-5-en-2-yl)-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one

1 reference

6-[(3aR,5aS,9aS,11aR)-3a,6,6,9a,11a-pentamethyl-4,7-dioxo-1H,2H,3H,5H,5aH,8H,9H,10H,11H-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

1 reference

1 reference

1 reference

6-[(5R,10S,13R,14R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(E)-6-[(7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid

1 reference

Jie Liu

1

1 reference

30 July 2017

Kenji Kurashiki

series ordinal

2

1 reference

30 July 2017

Kuniyoshi Shimizu

series ordinal

3

1 reference

30 July 2017

Ryuichiro Kondo

series ordinal

4

1 reference

30 July 2017

publication date

2006

1 reference

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/bpb/29/2/29_2_392/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/bpb.29.392?email=unpaywall_01@example.com

published in

Biological and Pharmaceutical Bulletin

1 reference

30 July 2017

volume

29

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

392-395

1 reference

https://api.unpaywall.org/v2/10.1248/bpb.29.392?email=unpaywall_01@example.com

30 July 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes fromGanoderma lucidum (FR.) KARST.

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/HLCA.19820650221

COCI

reference URL

Ganoderiol A and B, new triterpenoids from the fungus Ganoderma lucidum (Reishi).

9 March 2024

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB1961.50.2887

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Erectile dysfunction following treatments of benign prostatic hyperplasia: a prospective study

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Two New Lanostanoids from Ganoderma lucidum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Steroid 5 alpha-reductase: two genes/two enzymes

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Anti-androgenic activities of Ganoderma lucidum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Inhibitors of steroid 5 alpha-reductase in benign prostatic hyperplasia, male pattern baldness and acne

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Three new lanostanoids from Ganoderma lucidum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

The 5 alpha-reductase inhibitory components from heartwood of Artocarpus incisus: structure-activity investigations

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

The influence of finasteride on the development of prostate cancer

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Bitter triterpenoids from the fungus Ganoderma applanatum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

New lanostanoids from the fungus Ganoderma concinna.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.29.392

Identifiers

DOI

10.1248/BPB.29.392

1 reference

30 July 2017

1 reference